Abstract
Although there are many possible ways to treat skin cancer, most skin cancers are effectively treated by complete excision followed by standard histologic evaluation to ensure clear margins. The bread loaf technique describes a common method of processing specimens in which multiple slices of tissue are taken perpendicular to the major axis of an excision and submitted for microscopic analysis. Although sections may only be approximately four microns thick (0.000004 meters), this method is associated with high cure rates for basal cell and squamous cell carcinoma. Some authors have stated that this technique assesses less than 1% of the margins. We critically reviewed this assumption. While we confirm that the bread loaf technique often directly visualizes 1% or less of the peripheral and deep margins when considering only the width of sections compared to the entire length of an excisional specimen of the excision, much useful additional information is gained as soon as clear sections are identified towards the tips of a typical excisional specimen. For tumors that tend to grow in a nodular or spherical arrangement such as nodular basal cell carcinoma or squamous cell carcinoma of keratoacanthomatous type, we show that a variable but significant portion of the margin may be considered sampled by proxy when slice faces are clear. We highlight the importance of understanding the principles involved in tissue sectioning in order to allow clinicians to make informed decisions on behalf of patients.
Competing Interest Statement
Robert T. Brodell is a principal investigator for a clinical trial (Novartis) and for the Corevitas psoriasis biologic registry. Stock ownership: Veradermics Inc. Educational Grants: Pfizer. He serves on editorial boards of American Medical Student Research Journal (faculty advisor); Practice Update Dermatology (Editor-in-Chief); Journal of the American Academy of Dermatology (Associate Editor); Practical Dermatology; Journal of the Mississippi State Medical Society; SKIN: The Journal of Cutaneous Medicine and Archives of Dermatological Research. Melissa M. Warne and Matthew M. Klawonn have no conflicts of interest to report.
Funding Statement
There was no outside funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Not applicable.
